Authors

  • Muradova Railya Rustamovna
    Assistant at the Department of Clinical Pharmacology, Samarkand State Medical University, Samarkand, Uzbekistan

DOI:

https://doi.org/10.37547/ijmscr/Volume04Issue06-13

Keywords:

Multitasking Cognitive overload Decreased productivity

Abstract

This article explores the detrimental effects of both polyparasmia (multitasking) and polypharmacy (prescribing multiple medications) on individual health and well-being. Polyparasmia can lead to cognitive overload, decreased productivity, and stress, impacting mental and physical health. On the other hand, polypharmacy increases the risk of adverse drug interactions, side effects, non-adherence to medication regimens, and higher healthcare costs. Healthcare providers and patients need to be aware of these risks and work together to optimize treatment plans and minimize the complications associated with multitasking and polypharmacy.


background image

Volume 04 Issue 06-2024

84


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

06

P

AGES

:

84-88

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

ABSTRACT

This article explores the detrimental effects of both polyparasmia (multitasking) and polypharmacy (prescribing

multiple medications) on individual health and well-being. Polyparasmia can lead to cognitive overload, decreased

productivity, and stress, impacting mental and physical health. On the other hand, polypharmacy increases the risk of

adverse drug interactions, side effects, non-adherence to medication regimens, and higher healthcare costs.

Healthcare providers and patients need to be aware of these risks and work together to optimize treatment plans and

minimize the complications associated with multitasking and polypharmacy.

KEYWORDS

Multitasking, Polyparasmia, Cognitive overload, Decreased productivity, Mental health, Anxiety, Cognitive

impairment, Cortisol, Sleep disruption, Well-being, Mindfulness.

INTRODUCTION

In our fast-paced world filled with constant demands

on our time and attention, multitasking has become

increasingly prevalent. However, engaging in multiple

tasks simultaneously, known as polyparasmia, may

have detrimental effects on our health.

Polyparasmia, also referred to as multitasking, is the

act of performing two or more tasks simultaneously.

While it may seem like a time-saving and efficient way

to manage our busy schedules, research suggests that

the human brain is not designed to focus on multiple

Research Article

THE IMPACT OF POLYPARASMIA ON HEALTH: UNDERSTANDING THE
DANGERS OF MULTITASKING

Submission Date:

June 18, 2024,

Accepted Date:

June 23, 2024,

Published Date:

June 28, 2024

Crossref doi:

https://doi.org/10.37547/ijmscr/Volume04Issue06-13


Muradova Railya Rustamovna

Assistant at the Department of Clinical Pharmacology, Samarkand State Medical University, Samarkand,
Uzbekistan


Journal

Website:

https://theusajournals.
com/index.php/ijmscr

Copyright:

Original

content from this work
may be used under the
terms of the creative
commons

attributes

4.0 licence.


background image

Volume 04 Issue 06-2024

85


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

06

P

AGES

:

84-88

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

tasks at once. Studies have shown that multitasking

can lead to decreased productivity, increased stress

levels, and even cognitive impairment.

One of the key dangers of polyparasmia is the negative

impact it can have on mental health. Constantly

switching between tasks can overwhelm the brain,

leading to cognitive overload and decreased ability to

focus. This can result in increased levels of stress,

anxiety, and feelings of being overwhelmed, ultimately

contributing to a decline in mental well-being.

Furthermore, polyparasmia can also have physical

health consequences. Research has shown that

individuals who engage in frequent multitasking may

experience higher levels of cortisol, the stress

hormone, which can harm the div over time.

Additionally, multitasking has been linked to disrupted

sleep patterns, which can impair the div's ability to

rest and recover, leading to fatigue and decreased

overall health.

To combat the negative effects of polyparasmia on

health, it is important to practice mindfulness and

prioritize single-tasking. By focusing on one task at a

time, we can improve our concentration, productivity,

and overall well-being. Additionally, setting boundaries

and creating a schedule that allows for dedicated time

to focus on individual tasks can help reduce the

temptation to multitask.

Complications of polypharmacy, or the prescribing of

multiple medications, can have significant implications

for an individual's health. When a person is prescribed

more than three medications, the risk of adverse drug

interactions, side effects, and non-adherence to the

prescribed regimens increases. These complications

can lead to a range of negative outcomes, including

adverse health effects, decreased quality of life, and

increased healthcare costs.

One of the most concerning complications of

polypharmacy is the potential for adverse drug

interactions. When multiple medications are taken

simultaneously, there is an increased risk of these

medications interacting in ways that can amplify or

negate their effects. This can lead to unexpected side

effects, reduced efficacy of certain medications, or

even toxic reactions within the div. Adverse drug

interactions can result in exacerbation of existing

health conditions, the development of new symptoms,

and increased hospitalization rates.

Additionally, the more medications a person is

prescribed, the higher the likelihood of experiencing

side effects from one or more of the drugs. Common

side

effects

such

as

dizziness,

drowsiness,

gastrointestinal disturbances, and allergic reactions

can significantly impact an individual's quality of life

and may even necessitate the discontinuation of

certain medications.


background image

Volume 04 Issue 06-2024

86


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

06

P

AGES

:

84-88

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

Non-adherence to prescribed medication regimens is

another potential complication of polypharmacy. As

the number of prescribed medications increases, the

complexity of the medication regimen also rises,

making it more challenging for individuals to adhere to

their prescribed treatment plans. Non-adherence can

lead to inadequate management of chronic conditions,

disease progression, and an increased risk of

hospitalization or emergency room visits.

Furthermore, polypharmacy can contribute to

increased healthcare costs. The need for multiple

medications often results in higher medication

expenses, increased healthcare utilization due to

adverse reactions or non-adherence, and the need for

additional medical monitoring to manage potential

complications.

It is crucial for healthcare providers to carefully assess

the necessity and appropriateness of each prescribed

medication and to regularly review and reconcile a

patient's medication regimen. Patients should also be

educated about the potential risks and benefits of their

medications,

and

the

importance

of

open

communication with their healthcare team.

The World Health Organization (WHO) offers the

following recommendations to prevent polypharmacy

(taking multiple medications):

1. Medical Examination and Consultation: Consult with

a physician regularly to evaluate the need and

suitability of each prescribed medication, and to

periodically review and reconcile the medication

regimen.

2. Lifestyle: Maintain a healthy lifestyle, including

proper nutrition, physical activity and moderate

alcohol consumption, to reduce the need for

medications.

3. Patient Education: Educate patients about the

potential risks and benefits of medications and teach

them the importance of following recommended

treatment regimens.

4. Communication with Health Care Personnel:

Establish open communication with health care

providers, sharing all information about medications

taken, including not only prescription drugs, but also

over-the-counter drugs and supplements.

5. Regularly review and update your medication list:

Periodically update and review your list of all

medications you are taking, including sources of over-

the-counter medications.

These recommendations will help minimize the risks

associated with polypharmacy and ensure optimal

medication management to maintain the health and

well-being of patients.

CONCLUSION


background image

Volume 04 Issue 06-2024

87


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

06

P

AGES

:

84-88

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

Polyparasmia, or multitasking, can have a significant

impact on our health, both mentally and physically. By

understanding the dangers of trying to juggle multiple

tasks at once, we can take proactive steps to protect

our well-being and promote a healthier lifestyle.

Remember, sometimes it's better to slow down, focus

on one thing at a time, and prioritize our health above

all else.

In conclusion, polypharmacy can lead to a variety of

complications, including adverse drug interactions,

side effects, non-adherence, and increased healthcare

costs. Healthcare providers and patients need to work

collaboratively to minimize these risks and to ensure

that medication regimens are optimized for both

effectiveness and safety. Regular medication reviews

and open communication between patients and

healthcare providers are essential in addressing the

potential

complications

associated

with

polypharmacy.

REFERENCES

1.

Bushardt R. L. et al. Polypharmacy: misleading, but

manageable //Clinical interventions in aging.

2008.

Т. 3. –

№. 2. –

С. 383

-389.

2.

Masnoon N. et al. What is polypharmacy? A

systematic review of definitions //BMC geriatrics.

2017.

Т. 17. –

С. 1

-10.

3.

Muradova R. THE NEED FOR PHARMACOTHERAPY

WITH VITAMINS //Science and innovation.

2024.

Т. 3. –

№. D3. –

С. 188

-191.

4.

Muradova R., Haydarov M. MULTIPLE ORGAN

FAILURE IN CHILDREN WITH BURNS //Science and

innovation.

2023.

Т. 2. –

№. D2. –

С. 83

-90.

5.

Muradova R. TREATMENT OF BURN SEPSIS

AGAINST THE BACKGROUND OF MULTIPLE

ORGAN FAILURE IN CHILDREN //Science and

innovation.

2023.

Т. 2. –

№. D2. –

С. 227

-232.

6.

The National Institutes of Health (NIH)

7.

The World Health Organization (WHO)

8.

Аллазов С. А., Кaмaлoв Н. А., Мурадова Р. Р.

ЖИСТКОСТНЫЕ ОБЪЕМНЫЕ ОБРАЗОВАНИЯ

ПОЧЕК

(ОБЗОР

ЛИТЕРАТУРЫ)

//ЖУРНАЛ

РЕПРОДУКТИВНОГО

ЗДОРОВЬЯ

И

УРО

-

НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. –

2021.

Т. 2. –

№. 1.

9.

Ключников С. О. Полипрагмазия: пути решения

проблемы //Детские инфекции. –

2014.

Т. 13. –

№. 4. –

С. 36

-41.

10.

Мурадова Р. Р., Хайдаров М. М. КЛИНИКО

-

ФАРМАКОЛОГИЧЕСКИЕ

АСПЕКТЫ

ПРИМЕНЕНИЯ ГОРМОНАЛЬНЫХ ПРЕПАРАТОВ В

ОФТАЛЬМОЛОГИИ

//Достижения

науки

и

образования. –

2021.

№. 3 (75). –

С. 100

-102.

11.

Мурадова Р. Р., Хайдаров М. М., Бегнаева М. У.

Современные

клинико

-

фармакологические

аспекты

применения

нефротоксичных


background image

Volume 04 Issue 06-2024

88


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

06

P

AGES

:

84-88

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

антибиотиков

//Достижения

науки

и

образования. –

2021.

№. 3. –

С. 98

-100.

12.

Мурадова

Р.

Р.,

Хайдаров

М.

М.

ФОТОТОКСИЧЕСКИЕ И ФОТОАЛЛЕРГИЧЕСКИЕ

РЕАКЦИИ

ПРИ

ИСПОЛЬЗОВАНИИ

СОВРЕМЕННЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ И

НЕКОТОРЫХ РАСТЕНИЙ //Вопросы науки и

образования. –

2020.

№. 37 (121). –

С. 41

-44.

13.

Мурадова Р. Р., Хайдаров М. М., Омонов Э. М.

ОПТИМИЗАЦИЯ

ТЕРАПИИ

БОЛЬНЫХ

С

ОТКРЫТОУГОЛЬНОЙ ГЛАУКОМОЙ С УЧЕТОМ

ПАРАМЕТРОВ

СОСТОЯНИЯ

МИКРОЦИРКУЛЯТОРНОГО

РУСЛА

ЦЕНТРАЛЬНОЙ ЗОНЫ СЕТЧАТКИ //Вопросы

науки и образования. –

2021.

№. 10 (135). –

С. 66

-

69.

14.

Саломова С. Р. и др. Полипрагмазия в педиатрии

//Педиатрическая фармакология. –

2009.

Т. 6. –

№. 5. –

С. 107

-109.

15.

Сычев Д. А. и др. Полипрагмазия: взгляд

клинического фармаколога //Терапевтический

архив. –

2016.

Т. 88. –

№. 12. –

С. 94

-102.

16.

Хайдаров М. М., Мурадова Р. Р., Худойбердиева

Г.

С.

Оптимизация

премедикации

при

хирургических вмешательствах в гинекологии

//Достижения науки и образования. –

2020.

№.

5 (59).

С. 98

-102.

17.

Хайдаров

М.

М.,

Мурадова

Р.

Р.

Гепатотоксичность лекарственных средств как

одна из проблем современной медицины

//Наука через призму времени. –

2020.

№. 11. –

С. 46

-49.

18.

Эшназарова Г. и др. ОСНОВНЫЕ ПОНЯТИЯ

БИОТЕХНОЛОГИЧЕСКОГО

ПОЛУЧЕНИЯ

ЛЕКАРСТВ

//Бюллетень

студентов

нового

Узбекистана. –

2024.

Т. 2. –

№. 2. –

С. 11

-15.

19.

https://ru.wikipedia.org/wiki/%D0%9F%D0%BE%D0%

BB%D0%B8%D0%BF%D1%80%D0%B0%D0%B3%D0%BC

%D0%B0%D0%B7%D0%B8%D1%8F

References

Bushardt R. L. et al. Polypharmacy: misleading, but manageable //Clinical interventions in aging. – 2008. – Т. 3. – №. 2. – С. 383-389.

Masnoon N. et al. What is polypharmacy? A systematic review of definitions //BMC geriatrics. – 2017. – Т. 17. – С. 1-10.

Muradova R. THE NEED FOR PHARMACOTHERAPY WITH VITAMINS //Science and innovation. – 2024. – Т. 3. – №. D3. – С. 188-191.

Muradova R., Haydarov M. MULTIPLE ORGAN FAILURE IN CHILDREN WITH BURNS //Science and innovation. – 2023. – Т. 2. – №. D2. – С. 83-90.

Muradova R. TREATMENT OF BURN SEPSIS AGAINST THE BACKGROUND OF MULTIPLE ORGAN FAILURE IN CHILDREN //Science and innovation. – 2023. – Т. 2. – №. D2. – С. 227-232.

The National Institutes of Health (NIH)

The World Health Organization (WHO)

Аллазов С. А., Кaмaлoв Н. А., Мурадова Р. Р. ЖИСТКОСТНЫЕ ОБЪЕМНЫЕ ОБРАЗОВАНИЯ ПОЧЕК (ОБЗОР ЛИТЕРАТУРЫ) //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2021. – Т. 2. – №. 1.

Ключников С. О. Полипрагмазия: пути решения проблемы //Детские инфекции. – 2014. – Т. 13. – №. 4. – С. 36-41.

Мурадова Р. Р., Хайдаров М. М. КЛИНИКО-ФАРМАКОЛОГИЧЕСКИЕ АСПЕКТЫ ПРИМЕНЕНИЯ ГОРМОНАЛЬНЫХ ПРЕПАРАТОВ В ОФТАЛЬМОЛОГИИ //Достижения науки и образования. – 2021. – №. 3 (75). – С. 100-102.

Мурадова Р. Р., Хайдаров М. М., Бегнаева М. У. Современные клинико-фармакологические аспекты применения нефротоксичных антибиотиков //Достижения науки и образования. – 2021. – №. 3. – С. 98-100.

Мурадова Р. Р., Хайдаров М. М. ФОТОТОКСИЧЕСКИЕ И ФОТОАЛЛЕРГИЧЕСКИЕ РЕАКЦИИ ПРИ ИСПОЛЬЗОВАНИИ СОВРЕМЕННЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ И НЕКОТОРЫХ РАСТЕНИЙ //Вопросы науки и образования. – 2020. – №. 37 (121). – С. 41-44.

Мурадова Р. Р., Хайдаров М. М., Омонов Э. М. ОПТИМИЗАЦИЯ ТЕРАПИИ БОЛЬНЫХ С ОТКРЫТОУГОЛЬНОЙ ГЛАУКОМОЙ С УЧЕТОМ ПАРАМЕТРОВ СОСТОЯНИЯ МИКРОЦИРКУЛЯТОРНОГО РУСЛА ЦЕНТРАЛЬНОЙ ЗОНЫ СЕТЧАТКИ //Вопросы науки и образования. – 2021. – №. 10 (135). – С. 66-69.

Саломова С. Р. и др. Полипрагмазия в педиатрии //Педиатрическая фармакология. – 2009. – Т. 6. – №. 5. – С. 107-109.

Сычев Д. А. и др. Полипрагмазия: взгляд клинического фармаколога //Терапевтический архив. – 2016. – Т. 88. – №. 12. – С. 94-102.

Хайдаров М. М., Мурадова Р. Р., Худойбердиева Г. С. Оптимизация премедикации при хирургических вмешательствах в гинекологии //Достижения науки и образования. – 2020. – №. 5 (59). – С. 98-102.

Хайдаров М. М., Мурадова Р. Р. Гепатотоксичность лекарственных средств как одна из проблем современной медицины //Наука через призму времени. – 2020. – №. 11. – С. 46-49.

Эшназарова Г. и др. ОСНОВНЫЕ ПОНЯТИЯ БИОТЕХНОЛОГИЧЕСКОГО ПОЛУЧЕНИЯ ЛЕКАРСТВ //Бюллетень студентов нового Узбекистана. – 2024. – Т. 2. – №. 2. – С. 11-15.